Brunel University Research Archive (BURA) >
University >
Publications >

Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/6138

Title: Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
Authors: Sapir, E
Gozaly-Chianea, Y
Al-Wahiby, S
Ravindran, S
Yasaei, H
Slijepcevic, P
Publication Date: 2011
Publisher: BioMed Central Ltd
Citation: Genome Integrity, 2(9), Dec 2011
Abstract: Background: Recent studies suggest that BRCA2 affects telomere maintenance. Interestingly, anti cancer treatments that involve BRCA2 and telomerase individually are currently being explored. In the light of the above recent studies their combinatorial targeting may be justified in the development of future treatments. In order to investigate effects of BRCA2 that can be explored for this combinatorial targeting we focused on the analysis of recombination rates at telomeres by monitoring T-SCEs (Telomere Sister Chromatid Exchanges). Results: We observed a significant increase in T-SCE frequencies in four BRCA2 defective human cell lines thus suggesting that BRCA2 suppresses recombination at telomeres. To test this hypothesis further we analyzed T-SCE frequencies in a set of Chinese hamster cell lines with or without functional BRCA2. Our results indicate that introduction of functional BRCA2 normalizes frequencies of T-SCEs thus supporting the notion that BRCA2 suppresses recombination at telomeres. Given that ALT (Alternative Lengthening of Telomeres) positive cells maintain telomeres by recombination we investigated the effect of BRCA2 depletion in these cells. Our results show that this depletion causes a dramatic reduction in T-SCE frequencies in ALT positive cells, but not in non-ALT cells. Conclusion: BRCA2 suppresses recombination at telomeres in cells that maintain them by conventional mechanisms. Furthermore, BRCA2 depletion in ALT positive cells reduces high levels of T-SCEs normally found in these cells. Our results could be potentially important for refining telomerase-based anti-cancer therapies.
Description: This article has been made available through the Brunel Open Access Publishing Fund - Copyright @ 2011 Sapir et al.
Sponsorship: This work is supported in part by grants from European Commission RISC-RAD contract FI6RCT2003-508842 and British Council
URI: http://www.genomeintegrity.com/content/2/1/9/abstract
http://bura.brunel.ac.uk/handle/2438/6138
DOI: http://dx.doi.org/10.1186/2041-9414-2-9
ISSN: 2041-9414
Appears in Collections:School of Health Sciences and Social Care Research Papers
Publications
Brunel OA Publishing Fund

Files in This Item:

File Description SizeFormat
Fulltext.pdf497.53 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.

 


Library (c) Brunel University.    Powered By: DSpace
Send us your
Feedback. Last Updated: September 14, 2010.
Managed by:
Hassan Bhuiyan